Hbk Investments L P Catalent, Inc. Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $3.19 Million - $6.73 Million	100,001 New	100,001 $4.34 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $4.55 Million - $5.25 Million	-122,081 Reduced 92.08%	10,500 $431,000
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $4.47 Million - $5.52 Million	132,581	132,581 $5.29 Million

422

147M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.